Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus by unknown
Autoantibodies against the Multicatalytic Proteinase
in Patients with Systemic Lupus Erythematosus
By Joaquin Arribas,* Maria Luz Rodriguez,*
Rita Alvarez-Do Forno,$ and Jose G. Castano*
From 'Departamento de Bioqulmica e Instituto de Investigaciones Biomidicas del CSIC,
Facultad de Medicina de la UAM, and tServicio de Inmunologia Ciudad Sanitaria La Paz,
28029 Madrid, Spain
Summary
Sera from patients with systemic lupus erythematosus contain specific autoantibodies directed
against different polypeptide components ofthe multicatalytic proteinase (alsoknown as proteasome
or prosome) . Thesehuman autoantibodies, in contrast to polyclonal antibodies obtained in rabbits
against the purified enzyme, recognize highly conserved epitopes of the multicatalytic proteinase
polypeptides from yeast to human .
Multicatalytic proteinase (MCP), I also known as protea-
some or prosome, is a recently described high molec-
ular weight proteinase composed of several polypeptides
ranging in size between 20 and 35 kD andshown to be iden-
tical to a previously described 19S particle present in all eu-
karyotes having a characteristic cylindrical shape formed by
four stacked rings (1-4) . The enzyme responsible for the pro-
cessing of the 5' end ofpretRNAs in X . laevis oocytes (5)
and aminoacyltransferase 1(6) has been shown to be associated
with this cylindrical particle . Here, we report, for the first
time, the presence with relative high frequency of antibodies
against the polypeptide components of this multicatalytic pro-
teinase in the sera of patients with SLE and the high degree
ofconservation of the epitopes recognized by these autoanti-
bodies during evolution from yeast to human .
Material and Methods
Screening ofPatient's Sera .
￿
MCP from yeast, X . laevis ovaries,
mouse EAC, and human erythrocytes was purified essentially as
described (7) andjudged 90-95% homogenous by SDS-PAGE. The
MCP was subjected to one- (S) or two-dimensional (9) elec-
trophoretic analysis, and either stained with Coomassie brilliant
blue or silver, respectively, or Western blotted (10) and probed with
sera of patients with autoimmune diseases at 1/100 dilution, as
described (11) . The blots were developed with peroxidase-labeled
goat anti-human antibodies (Cappel Laboratories, Cochranville,
PA) . Purified MCP was also probed against sera of these patients
by counterimmune electrophoresis (12).
Affinity Purification of Antibodies against the MCP Polypeptides.
The antibodies against MCP present in patient sera were affinity
purified essentially as described (13) . Briefly, purified MCP from
'Abbreviations used in this paper . EAC, Ehrlich ascites cells ; MCP, mul-
ticatalytic proteinase.
Ehrlich ascites cells (EAC) was subjected to SDS-PAGE, Western
blotted, and incubated with 0.5 ml of patient serum ; the localiza-
tion of anti-MCP antibodies was assessed by developing vertical
stripes cut from the sides with goat peroxidase-labeled anti-human
antibodies . The band containing anti-MCP autoantibodies was
washed with 0.2 M Gly, pH 2.4, to elute the bound antibodies .
This solution was immediately neutralized after elution with 0.5M
NaOH and diluted threefold with TBS (50mM Tris-Cl, pH 7.4,
150 mM NaCI) . Finally, the diluted and neutralized solution was
dialyzed against TBS, concentrated to 0.5 ml on a centrikon
ultrafilter, and used for immunoblot.
Obtention ofRabbit hlyclonalAntibodies against RatMCP .
￿
Rabbit
anti-ratMCP polyclonal antibodies were obtained by subcutaneous
injection of 100kg ofpurified rat liver MCP emulsified withCFA
(first injection) and three more injections (100 ug each) with IFA
at i-wk intervals . Serum was obtained 2wk after the last injection ;
the titer of the rabbit antiserum obtained was 1/1,000.
Results and Discussion
We initially purified the MCP from mouseEAC and used
the purified enzyme for a screening by immunoblot of sera
ofpatients with autoimmune diseases that have the following
clinical diagnoses: 43 patients had SLE, four had dermatomyo-
sitis, five had polymyositis, four had sclerodermia, and three
have been diagnosed with Sjogren syndrome . The presence
of antibodies against the polypeptides components oftheEAC
MCP was detected in 15 (35%) ofthe group ofpatients that
had SLE with titers that varied from 1/50 to 1/200 . None
of the other sera tested, including CDC reference sera against
U1 snRNP, Sm, La, and Ro, were positive, and a pool of
100 normal subjects was also negative (data not shown) . An
example of two of the positive sera is presented in Fig. 1 A .
The antibodies present in the serum of these patients also
recognized, as expected, thehomologoushuman erythrocyte
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￿
Characterization ofautoantibodies against multicatalytic pro-
teinase in sera of patients with SLE . (A) Lane 1, One-dimensional SDS-
PAGE of the purified enzyme fromEAC stained with Coomassiebrilliant
blue; lanes 2 and 3, Western blot probed with S-122 and R4392 sera from
SLE patients, respectively. (B)EAC multicatalytic proteinase proteinsana-
lyzed by two-dimensional gel electrophoresis. Lane 1, silver-stained gel ;
lane 2, two-dimensional blot probed with S-122 serum ; lane 3, two-
dimensionalblot probedwith R4392 serum; (C) SDS-PAGE ofMCP from
human erythrocytes stained with Coomassie brilliant blue (lane 1) or
Western blotted and probed with S-122 serum (lane 2) or R4392 serum
(lane 3) . (D) Counterimmune electrophoresis ofMCP from EAC against
5122 serum (lane 1) or R4392 serum (lane 2) . Antigen (20 ug) was placed
in the left wells, and sera were placed in the right wells (10 pl) . After
electrophoresis and washing, the strips were stained with Coomassieblue.
MCP (Fig. 1 C) . To further characterize the polypeptides
of the MCP to which these autoantibodies were directed,
two-dimensional immunoblotting of EAC MCP was per-
formed. Results of this analysis for the sera of the two pa-
tients shown in A are presented in Fig. 1 B . From several
different preparations ofEACMCP, eight polypeptides were
consistently observed by two-dimensional analysis and are
numbered 1-8 (Fig. 1 B, lane 1) . The serum of patient S122
mainly recognized polypeptide 1 (Fig. 1 B, lane 2), and the
sera R4392 recognized polypeptides 3 and 8 (Fig. 1 B, lane
3) . In Fig. 1 D, the results of counterimmune electropho-
resis against the nativeMCP of the two sera presented above
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are shown . The formation of a precipitation line indicates
that the autoantibodies present in those sera are able to recog-
nize the native MCP and to form immunoprecipitable com-
plexes. Autoantibodies directed against each of the polypep-
tides of the MCP have been found, but individual serum
recognizes one or two of those polypeptides, and no serum
has been found to recognize the whole set of polypeptides
of the MCP or to inhibit its proteinase activity when added
directly to MCP. These results indicate that the immune re-
sponse against individual MCP proteins differs from patient
to patient and either some of the protein components of the
MCP share common epitopes or, alternatively, some of the
polypeptide bands observed may be derived from others by
autocleavage due to the proteolytic activity of MCP (14) .
When different amounts of the 15 different positive sera
(10-100 A1) from the patients, either total serum or affinity
purified (see below), were incubated in the presence of 2 Ag
of the purified human erythrocyte MCP, there was no inhi-
bition (100% of the enzymatic activity either in the presence
or in the absence of antibody) of the proteolytic activity of
the MCP as assayed with three fluorescent model substrates
(ARR, for trypsin-like activity, LLVY for chymotrypsin-like
activity, and LLE for peptidylglutamyl-peptide hydrolytic ac-
tivity ; see reference 7 for details of the assay procedure) . Simi-
larly, 80-90% of the enzymatic activity was recovered in the
pellet of the immunoprecipitation of the antigen antibody
complex with protein A-Sepharose. These results indicate that
none of the autoantibodies we have detected are blocking
antibodies either in solution or after immunoprecipitation
of the immune antigen-antibody complex with protein
A-Sepharose .
SLE patients frequently have more than one type of au-
toantibodies (15), so it could be possible that antibodies de-
tected in the serum of these patients were directed against
other antigens showing simple crossreaction with the par-
ticle polypeptides. To clarify this point, the antibodies bound
to transferred particle polypeptides were eluted and tested for
specificity . Proteins from the different fractions obtained
through the purification ofEAC MCP were separated by SDS-
PAGE, transferred, and immunoblots were done with R4392
serum unpurified or affinity purified as indicated above . The
results of this experiment (presented in Fig. 2) show that,
as expected, the unpurified R4392 serum recognize several
polypeptides in fractions from early steps of purification apart
of theMCP polypeptides, but after purification, only the poly-
peptide components of the MCP are recognized in all frac-
tions . This result indicates that genuine specific antibodies
against MCP polypeptides are present in this patient . Similar
results have been obtained with five other positive sera (data
not shown) .
As already shown above, the autoantibodies detected recog-
nize both human and mouse MCP polypeptides, indicating
a certain degree of conservation of the recognized epitopes.
To further explore this conservation, the MCP from yeast,
X. laevu ovaries, rat liver, andhuman erythrocytes were purified
and their protein components were probed by immunoblots
with human serum . Fig . 3 shows that R4392 serum (C) and
Multicatalytic Proteinase Antibodies in Systemic Lupus ErythematosusR5192 serum (D) recognize similar polypeptides in all four
MCP, similar results have been obtained with four other
human sera (data not shown) . These results clearly point out
the high degree of conservation of the epitopes recognized
by thehuman autoantibodies. In contrast, a rabbit polyclonal
antibody obtained against the native MCP from rat liver (Fig.
Figure 2 .
￿
Specific anti-MCP an-
tibodies are actually present in the
serum of SLE patients. SDS-PAGE
of the different steps of the puri-
fication ofMCP fromEAC (see ref-
erence 7): lanes 1, high-speed super-
nant of the homogenate (100,000 g,
60 min) ; lanes 2, DEAF-cellulose;
lanes 3, hydroxyapatite ; lanes 4,
DEAE-AfFigel blue ; lanes 5, gly-
cerol gradient. (Left panel) Gel
stained with Coomassie Blue; (center
panel) immunoblot ofthe same frac-
tions with R4392 serum ; (right
panel) immunoblot ofthe same frac-
tions probed with anti-MCP anti-
bodies affinity purified from R4392
serum .
3 B) recognizes almost the whole set of polypeptides of the
MCP from rat liver and shows almost no crossreaction with
yeast MCP polypeptides . Similar results have been reported
with polyclonal antibodies obtained against MCP from one
eukaryotic species showing poor crossreactivity with MCP
from other species (16) .
Figure 3 .
￿
Conservation of the epitopes ofMCP recognized by serum of patients with SLE . MCP was purified from different sources essentially
as described (7) and analyzed by SDS-PAGE yeast (lane 1), X. laevis ovaries (lane 2), rat liver (lane 3), and human erythrocytes (lane 4) and either
stained with Coomassie blue (A) or transferred and immunoblotted with rabbit antiserum (B), human S-122 serum (C), and R4392 serum (D) at
1/100 dilution . The blots were developed with corresponding peroxidase-labeled goat anti-rabbit or goat anti-human antibodies.
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Arribas et al .Evidence has been presented for the presence of specific
antibodies against the polypeptide components of the mul-
ticatalytic proteinase in35% of patients with SLE . This fre-
quency is within the range of autoantibodies against snRNPs
(15) . Increasing evidence indicates that the autoimmune re-
sponse is antigen driven, but for most of the autoantigens
characterized in SLE patients, except for DNA, no evidence
has been presented of circulating antigens that can form com-
plexes with the autoantibodies (15) . The MCP is a protease
with unknown function in the cell . Within the cell, it seems
to be located both in the nucleus and the cytoplasm (2, 17-21),
and in early descriptions (22), was also found in the culture
media of tumor cells. The fact that MCP is also present in
circulating nonnucleated cells, like the erythrocytes (21, present
report), and in platelets (Arribas, J ., and J . G. Castano, un-
published results), makes its presence in plasma very likely
and available to form immune complexes in patients that have
autoantibodies. As the autoantibodies detected do not inhibit
the proteinase activity ofthe MCP, these immune complexes
could be involved, directly or indirectly, in attacking mem-
brane proteins producing cell damage as a part of the com-
plex response that eventually produces the pathological le-
sions observed in different tissues of autoimmune patients .
Another interesting aspect is that the epitopes of the MCP
polypeptides recognized by the human autoantibodies are
highly conserved from yeast to human . This is in contrast
to the natural response observed against MCP antigen in
rabbits, suggesting a mono- or oligoclonal B cell activation
together with an unusual antigen presentation in SLE pa-
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tients or a selective immune response due to a particular in-
fectious (viral, bacterial, or fungi) antigen similar to MCP.
It has not been possible to identify a proteinase like MCP
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has been found in archaebacteria (23), and a similar structure
by electron microscopy has been described as part of the pro-
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The detection of these newly described autoantibodies
against the multicatalytic proteinase may be important for
the clinical diagnoses and prognoses ofcertain patients with
SLE . Further research will clarify the role of these autoanti-
bodies in the pathogenesis and etiology ofSLE and their pos-
sible existence in other autoimmune diseases .
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